MetrioPharm Investor Relations News Update


A Current Publication by Dr. Wolfgang Brysch on the Prevention and Treatment of Covid-19


Dear Shareholders

We are pleased to announce today that Dr. Wolfgang Brysch, in collaboration with a group of international scientists, published a paper on the apparent influence of age on the course of the Covid-19 disease, an immune deficiency often linked to the aging process, the growing, broader understanding of these interconnections, and the emerging potential for the improvement of Covid-19 therapies, using anti-oxidative agents and physical exercise in a complementary fashion.

We would also like to draw your attention to our blog post here.

For further company updates, please also follow our LinkedIn profile here.


Your contact:

MetrioPharm AG Eva Brysch Investor Relations Managerin          

Eva Brysch
Head of Investor Relations & Corporate Communications
Phone: +49-(0)30-3384-395-40
Mail: invest@metriopharm.com


 MetrioPharm AG Download PDF